TITLE

A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO)

AUTHOR(S)
Quinnell, Timothy G.; Bennett, Maxine; Jordan, Jake; Clutterbuck-James, Abigail L.; Davies, Michael G.; Smith, Ian E.; Oscroft, Nicholas; Pittman, Marcus A.; Cameron, Malcolm; Chadwick, Rebecca; Morrel, Mary J.; Glover, Matthew J.; Fox-Rushby, Julia A.; Sharples, Linda D.
PUB. DATE
October 2014
SOURCE
Thorax;Oct2014, Vol. 69 Issue 10, p938
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Rationale Mandibular advancement devices (MADs) are used to treat obstructive sleep apnoea-hypopnoea syndrome (OSAHS) but evidence is lacking regarding their clinical and cost-effectiveness in less severe disease. Objectives To compare clinical- and cost-effectiveness of a range of MADs against no treatment in mild to moderate OSAHS. Measurements and methods This open-label, randomised, controlled, crossover trial was undertaken at a UK sleep centre. Adults with Apnoea-Hypopnoea Index (AHI) 5-<30/h and Epworth Sleepiness Scale (ESS) score =9 underwent 6 weeks of treatment with three nonadjustable MADs: self-moulded (SleepPro 1; SP1); semi-bespoke (SleepPro 2; SP2); fully-bespoke MAD (bMAD); and 4 weeks no treatment. Primary outcome was AHI scored by a polysomnographer blinded to treatment. Secondary outcomes included ESS, quality of life, resource use and cost. Main results 90 patients were randomised and 83 were analysed. All devices reduced AHI compared with no treatment by 26% (95% CI 11% to 38%, p=0.001) for SP1, 33% (95% CI 24% to 41%) for SP2 and 36% (95% CI 24% to 45%, p<0.001) for bMAD. ESS was 1.51 (95% CI 0.73 to 2.29, p<0.001, SP1) to 2.37 (95% CI 1.53 to 3.22, p<0.001, bMAD) lower than no treatment (p<0.001 for all). Compliance was lower for SP1, which was the least preferred treatment at trial exit. All devices were cost-effective compared with no treatment at a £20 000/quality-adjusted life year (QALY) threshold. SP2 was the most cost-effective up to £39 800/QALY. Conclusions Non-adjustable MADs achieve clinically important improvements in mild to moderate OSAHS and are cost-effective. Of those trialled, the semi-bespoke MAD is an appropriate first choice.
ACCESSION #
98503802

 

Related Articles

  • Is automatic CPAP titration as effective as manual CPAP titration in OSAHS patients? A meta-analysis. Gao, Weijie; Jin, Yinghui; Wang, Yan; Sun, Mei; Chen, Baoyuan; Zhou, Ning; Deng, Yuan // Sleep & Breathing;Jun2012, Vol. 16 Issue 2, p329 

    Purpose: It is costly and time-consuming to conduct the standard manual titration to identify an effective pressure before continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) patients. Automatic titration is cheaper and more easily available than manual...

  • Randomised trial of compliance with flexible (C-Flex) and standard continuous positive airway pressure for severe obstructive sleep apnea. Alister Neill; Angela Campbell // Sleep & Breathing;Nov2008, Vol. 12 Issue 4, p393 

    Abstract Introduction  Obstructive sleep apnea (OSA) is often treated with continuous positive airway pressure (CPAP) but the effectiveness of treatment is probably limited by poor compliance. CPAP manufacturers are thus attempting to devise more comfortable PAP devices in an effort to...

  • Management of patients with obstructive sleep apnea. Ballard, Robert D. // Journal of Family Practice;Aug2008 Supplement, Vol. 57, pS24 

    The article elaborates on the proper management and treatment of patients with obstructive sleep apnea (OSA) in the U.S. There are several ways of managing patients with OSA, depending on the severity of the conditions which include weight loss, sleeping in a nonsupine position and avoidance of...

  • Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea. Chatterjee, Arjun B. // Evidence Based Medicine;Oct2009, Vol. 14 Issue 5, p11 

    The article presents a review of a research concerning the efficacy of continuous positive airway pressure (CPAP) devices for people with obstructive sleep apnoea. Through randomized controlled trials, researchers found out that CPAP are effective and cost-effective for obstructive sleep apnoea....

  • Yeah, But How Are They Doing 6 Months from Now? Phillips, Barbara A. // Internal Medicine Alert;2/28/2010, Vol. 32 Issue 4, p25 

    In this article the author discusses the study on weight reduction through low-calorie diet for the management of obstructive-sleep apnea (OSA).

  • Lose Weight in Your Belly for a Better Night's Sleep.  // Healthy Years;Jan2013, Vol. 10 Issue 1, p6 

    The article discusses research presented at the American Heart Association Scientific Sessions in November 2012 which found that losing weight can improve sleep quality. Loud snoring or gasping for breath during sleep, and excessive daytime sleepiness are the symptoms of sleep apnea. According...

  • Are You Lifestyle Ignoring Interventions Obstructive Sleep Apnea? Wickwire, Emerson M. // Sleep Review;Nov2013, Vol. 14 Issue 9, p14 

    The article offers tips for what works and what does not in offering patients with obstructive sleep apnea (OSA) lifestyle interventions (LIs). It discusses the benefits of LIs to the clinician and the patient, the needed considerations in terms of clinical suggestions for patients with moderate...

  • Losing Excess Weight Increases Chance of Eliminating Sleep Apnea.  // Mayo Clinic Women's Health Source;Mar2010, Vol. 14 Issue 3, p3 

    This article focuses on a study published in the "Archives of Internal Medicine" on September 28, 2009 which found that weight loss by overweight people can eliminate their problem of obstructive sleep apnea.

  • OBSTRUCTIVE SLEEP APNEA.  // Mayo Clinic Women's Health Source;Oct2007, Vol. 11 Issue 10, p4 

    The article offers medical information on sleep apnea. The common signs and symptoms of such sleep disorder are given, such as excessive daytime sleepiness and loud snoring. It discusses effective therapies for moderate to severe sleep apnea and other treatment options that may reduce the risk...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics